AEGON Asset Management (UK)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.18M | Buy |
215,051
+210,771
| +4,925% | +$5.51M | 0.06% | 123 |
|
|
2026
Q1 | $120K | Hold |
4,280
| – | – | ﹤0.01% | 160 |
|
|
2025
Q4 | $107K | Hold |
4,280
| – | – | ﹤0.01% | 157 |
|
|
2025
Q3 | $109K | Hold |
4,280
| – | – | ﹤0.01% | 152 |
|
|
2025
Q2 | $104K | Hold |
4,280
| – | – | ﹤0.01% | 150 |
|
|
2025
Q1 | $108K | Hold |
4,280
| – | – | ﹤0.01% | 151 |
|
|
2024
Q4 | $114K | Hold |
4,280
| – | – | ﹤0.01% | 144 |
|
|
2024
Q3 | $124K | Hold |
4,280
| – | – | ﹤0.01% | 141 |
|
|
2024
Q2 | $120K | Hold |
4,280
| – | – | ﹤0.01% | 140 |
|
|
2024
Q1 | $119K | Sell |
4,280
-2,131,224
| -100% | -$59.1M | ﹤0.01% | 141 |
|
|
2023
Q4 | $61.5M | Buy |
+2,135,504
| New | +$64.6M | 0.98% | 29 |
|
|
2023
Q2 | $78.9M | Hold |
2,153,152
| – | – | 1.28% | 16 |
|
|
2023
Q1 | $87.8M | Sell |
2,153,152
-349,268
| -14% | -$15.1M | 1.53% | 16 |
|
|
2022
Q4 | $128M | Hold |
2,502,420
| – | – | 2.32% | 7 |
|
|
2022
Q3 | $110M | Sell |
2,502,420
-284,996
| -10% | -$13.8M | 2.22% | 8 |
|
|
2022
Q2 | $146M | Sell |
2,787,416
-264,010
| -9% | -$13.5M | 2.76% | 4 |
|
|
2022
Q1 | $158M | Buy |
3,051,426
+986,567
| +48% | +$51.2M | 2.33% | 7 |
|
|
2021
Q4 | $122M | Sell |
2,064,859
-7,804
| -0.4% | -$387K | 1.57% | 13 |
|
|
2021
Q3 | $89.1M | Sell |
2,072,663
-393
| -0% | -$17.4K | 1.27% | 16 |
|
|
2021
Q2 | $81.2M | Sell |
2,073,056
-19,857
| -0.9% | -$772K | 1.15% | 16 |
|
|
2021
Q1 | $75.8M | Sell |
2,092,913
-136,813
| -6% | -$4.86M | 1.13% | 24 |
|
|
2020
Q4 | $82M | Buy |
2,229,726
+144,843
| +7% | +$5.31M | 1.2% | 21 |
|
|
2020
Q3 | $72.6M | Buy |
2,084,883
+1,192
| +0.1% | +$41.8K | 1.47% | 19 |
|
|
2020
Q2 | $64.6M | Sell |
2,083,691
-297,179
| -12% | -$10.1M | 1.45% | 22 |
|
|
2020
Q1 | $73.7M | Buy |
2,380,870
+71,100
| +3% | +$2.42M | 2.12% | 11 |
|
|
2019
Q4 | $85.8M | Buy |
2,309,770
+181,310
| +9% | +$6.46M | 2.05% | 13 |
|
|
2019
Q3 | $72.5M | Buy |
2,128,460
+50,579
| +2% | +$1.84M | 1.91% | 17 |
|
|
2019
Q2 | $85.4M | Sell |
2,077,881
-102,254
| -5% | -$4.06M | 2.31% | 14 |
|
|
2019
Q1 | $87.8M | Buy |
2,180,135
+20,974
| +1% | +$840K | 2.49% | 13 |
|
|
2018
Q4 | $89.4M | Buy |
2,159,161
+1,473,301
| +215% | +$61.2M | 2.86% | 8 |
|
|
2018
Q3 | $28.7M | Sell |
685,860
-16,375
| -2% | -$630K | 0.68% | 53 |
|
|
2018
Q2 | $24.2M | Sell |
702,235
-212,358
| -23% | -$7.26M | 0.59% | 55 |
|
|
2018
Q1 | $30.8M | Buy |
914,593
+112,610
| +14% | +$3.87M | 0.79% | 49 |
|
|
2017
Q4 | $27.6M | Sell |
801,983
-5,016
| -0.6% | -$171K | 0.7% | 54 |
|
|
2017
Q3 | $27.3M | Sell |
806,999
-33,929
| -4% | -$1.09M | 0.75% | 46 |
|
|
2017
Q2 | $26.8M | Sell |
840,928
-186,565
| -18% | -$5.88M | 0.75% | 46 |
|
|
2017
Q1 | $33.3M | Sell |
1,027,493
-134,036
| -12% | -$4.23M | 0.9% | 43 |
|
|
2016
Q4 | $35.8M | Sell |
1,161,529
-201,638
| -15% | -$6.16M | 1.01% | 38 |
|
|
2016
Q3 | $43.8M | Sell |
1,363,167
-59,908
| -4% | -$2M | 1.23% | 32 |
|
|
2016
Q2 | $47.5M | Buy |
1,423,075
+8,834
| +0.6% | +$282K | 1.36% | 30 |
|
|
2016
Q1 | $39.7M | Sell |
1,414,241
-10,107
| -0.7% | -$289K | 1.2% | 31 |
|
|
2015
Q4 | $43.6M | Sell |
1,424,348
-465,571
| -25% | -$14.6M | 1.27% | 28 |
|
|
2015
Q3 | $56.3M | Sell |
1,889,919
-170,800
| -8% | -$5.48M | 1.7% | 19 |
|
|
2015
Q2 | $65.5M | Sell |
2,060,719
-207,240
| -9% | -$6.75M | 1.82% | 16 |
|
|
2015
Q1 | $74.9M | Buy |
2,267,959
+549,127
| +32% | +$17.5M | 1.97% | 17 |
|
|
2014
Q4 | $50.8M | Sell |
1,718,832
-140,442
| -8% | -$4.03M | 5.61% | 2 |
|
|
2014
Q3 | $52.2M | Sell |
1,859,274
-4,205
| -0.2% | -$118K | 5.92% | 2 |
|
|
2014
Q2 | $52.5M | Buy |
1,863,479
+32,210
| +2% | +$918K | 6.02% | 3 |
|
|
2014
Q1 | $55.8M | Sell |
1,831,269
-271,754
| -13% | -$8.1M | 6.42% | 2 |
|
|
2013
Q4 | $61.1M | Buy |
2,103,023
+351,827
| +20% | +$10.2M | 8.72% | 1 |
|
|
2013
Q3 | $47.7M | Sell |
1,751,196
-6,571
| -0.4% | -$179K | 10.53% | 2 |
|
|
2013
Q2 | $46.8M | Buy |
+1,757,767
| New | +$48.6M | 10.95% | 1 |
|
Other funds holding PFE
AIM
SLAM
CWP
AEGON Asset Management (UK)'s PFE Position: Q2 2026 in Review
AEGON Asset Management (UK) increased its Pfizer (PFE) stake by 4,925% in Q2 2026, buying an estimated $5.51M and bringing the position to 215,051 shares worth $5.18M. The position accounts for 0.06% of the portfolio, ranked #123.
AEGON Asset Management (UK) first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $158M in Q1 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- AEGON Asset Management (UK) held 215,051 shares of Pfizer worth $5.18M as of Q2 2026.
- AEGON Asset Management (UK) bought 210,771 Pfizer shares in Q2 2026, an estimated $5.51M.
- Pfizer made up 0.06% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #123 holding.
- AEGON Asset Management (UK) first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- AEGON Asset Management (UK)'s Pfizer position peaked at $158M in Q1 2022.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.